Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 28, 2015 07:34 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Responds to Inquiries From Investors and the Scientific Community About Its Immuno-Oncology Cell Therapy Platform

SHANGHAI, China and PALO ALTO, Calif., Sept. 28, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
September 16, 2015 09:16 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group to Present CAR-T Phase I Clinical Trial Data for Non Small Cell Lung Cancer and Other Solid Tumors at 5th World Congress on Cancer Therapy

SHANGHAI, China and PALO ALTO, Calif., Sept. 16, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
September 14, 2015 09:25 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group to Release CAR-T for Non-Small Cell Lung Cancer Phase I Clinical Trial Data at 2015 European Cancer Congress

SHANGHAI, China and PALO ALTO, Calif., Sept. 14, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
August 14, 2015 07:00 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Reports Second Quarter and First Half 2015 Financial Results and Business Highlights

SHANGHAI, China and PALO ALTO, Calif., Aug. 14, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
August 11, 2015 08:34 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Appoints Former MedImmune/AstraZeneca Director, Yihong Yao, Ph.D., B.S., as Chief Scientific Officer

SHANGHAI, China and PALO ALTO, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
August 07, 2015 09:00 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group to Present at the Inaugural Meeting of Cartilage Repair and Applications Committee of the Chinese Society for Biomaterials

SHANGHAI, China and PALO ALTO, Calif., Aug. 7, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
July 27, 2015 08:25 ET | Source: Cellular Biomedicine Group Inc.

CBMG Announces Successful New Certifications for Proprietary Cell and Tissue Preservation Media Kits

SHANGHAI, China and PALO ALTO, Calif., July 27, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of...
July 08, 2015 08:52 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Appoints Alan List, MD as Chair of Scientific Advisory Board

SHANGHAI, China and PALO ALTO, Calif., July 8, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new...
June 30, 2015 09:17 ET | Source: Cellular Biomedicine Group Inc.

CBMG Today Responded to the Class Action Lawsuit

SHANGHAI, China and PALO ALTO, Calif., June 30, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new...
June 29, 2015 09:00 ET | Source: Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Completes Acquisition of CD40LGVAX Vaccine

SHANGHAI, China and PALO ALTO, Calif., June 29, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of new...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right